A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 9/29/2010

Posted by | 4:49pm on Wednesday, September 29, 2010

:
Good morning & welcome to the quarterly morning edition of #socpharm. Plse introduce yourself & say why you are interested in this topic.

:
I’m Eileen, work for Siren where we focus on relationship marketing for #rarediseases & love all things interwebs #socpharm

:
@ Good morning Brad, that’s a good topic: how do companies develop best practices around sm? #socpharm

:
RT @: Good morning & welcome to quarterly edition of #socpharm. Plse intro. yourself & say why your interested in topic. #DelBio

:
I’m Steve Woodruff and I’m the eHarmony of pharma training and marketing. #socpharm

:
What a gr8 description of what you do! RT @: I’m Steve Woodruff and I’m the eHarmony of pharma training and marketing. #socpharm

:
Hi everyone in #socpharm – I work at @ & provide SM platforms, community management & content moderation services to pharma cos

:
T1: How have you seen companies develop best practices around sm, which is new/evolving? #socpharm

:
I apologize in advance #socpharm tweeps that I’m a bit distracted because I’m at #epatcon which is just starting.

:
Is it easier if you get an outside consultant to come in & help lead a team to develop best practices? #socpharm

:
#socpharm tweeps: @ is ours today! ~ Signed: a happy #epatcon attendee. ;)

:
T1: i still think you’ve got to have a few people who know what to ask the agencies. Otherwise you’re at a major disadvantage. #socpharm

:
I would think that an outside consultant can help at least create the basic framework. But no company should try to… #socpharm

:
…short-circuit the process of creating something very specific that reflects company culture and policy (and goals!) #socpharm

:
Now I’m being distracted by our meeting. Since I’m being paid to be here & in the front row I need to at least pretend to focus :) #socpharm

:
@ Absolutely. Can the desire for development of best practices come from the bottom or does it need to be top down? #socpharm

:
Good morning! joining #socpharm for 1st time in months. Dana Webster, SM Specialist @ ParaPRO (Pharma co) & former field rep

:
consultants can be helpful to teach tools, SM core philosophies-I believe co. has to create policy based upon their core values #socpharm

:
T2: In keeping w/ePatient theme, check out @‘s blog abt retiring the term epatienthttp://bit.ly/bcovmo Agree? #socpharm

:
@ No worries, tx for joining in briefly. Twitter search is SO slow this morning, our chat isn’t very dynamic! #socpharm

:
@ @ I suspect it can be spurred from the bottom, but ultimately has to be driven to final form from top. #socpharm

:
I just checked Twitter status and it’s down!! #socpharm

:
yes. accept there is no dif RT @ check out @‘s blog a/b retiring term epatient http://bit.ly/bcovmo Agree? #socpharm

:
The Twitter status update itself is down I mean #socpharm

:
hello #socpharm I’m an independent consultant in digi pharma based in EU – will only be popping in & out as multitasking today

:
@ Maureen Byrne from some company called Novartis now speaking at ePatient Conference…! #socpharm

:
@ re @ I personally believe the bottom dwellers should help shape BP’s bcuz of more direct cust. contac #socpharm

:
An outside consultant can be useful in providing an outside view and objectivity but core needs to be done internally #socpharm

:
T2: Yesterday @ on Facebook asked abt epatient term: “When dr has to google your disease have to be empowered patient” #socpharm

:
T2: I have no problem w/e-pat term. Too many patients are apathetic, I think e-patient is a positive designation. I am an e-pat #socpharm

:
Very smart! RT @: “Social Sharing Tools in Pharma and Healthcare ? A New Solution”http://t.co/b4i0DAI #fdasm #socpharm

:
T3: What do you think of Novartis doing a CF video about a patient experience but using an actor? Openly disclosed. #socpharm

:
Sorry everyone, gave up on #socpharm due to Twitter issues. See you next Wed at usual time 8 pm EST.

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com